RxDoctor Payments Data

Shahrukh Malghani

Hospitalist · Rochelle, ILNPI 1568878718

Payments from drug & device makers

$570in general payments, 2019–2025

Across 28 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$130
  • Johnson & Johnson$77
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
  • Chiesi USA, Inc.$70
  • Boehringer Ingelheim$66
  • Pfizer$45
  • plus $108 from 5 others

What the payments were for

  • Food & beverage$570100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$570 in reported general payments places this provider in the 85th percentile of 1,328 hospitalist providers in Illinois.

See all hospitalist providers in Illinois

Medicare billing

Part B allowed, 2024
$171,142
Medicare patients
651
Services billed
1,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin31$54,800
EliquisApixaban97$30,957
XareltoRivaroxaban60$14,833
JardianceEmpagliflozin31$10,709
FarxigaDapagliflozin Propanediol24$7,144
Incruse ElliptaUmeclidinium Bromide19$4,711
Tresiba Flextouch U-200Insulin Degludec20$4,399
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog45$3,919
Memantine Hcl54$3,717
Potassium Chloride77$2,945
Atorvastatin Calcium247$2,399
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,234
Quetiapine Fumarate121$2,149
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$1,962
Celecoxib21$1,704

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$75$54,80031 claims
PfizerEliquis$45$30,95797 claims
Johnson & JohnsonXarelto$77$14,83360 claims
Boehringer IngelheimJardiance$66$10,70931 claims
AstraZenecaFarxiga$11$7,14424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,328 hospitalist providers in Illinois.

Other hospitalist in Rochelle

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →